Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
112.71
-0.24 (-0.21%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Lantheus Holdings Revenue

Lantheus Holdings had revenue of $369.98M in the quarter ending March 31, 2024, with 23.00% growth. This brings the company's revenue in the last twelve months to $1.37B, up 32.98% year-over-year. In the year 2023, Lantheus Holdings had annual revenue of $1.30B with 38.65% growth.

Revenue (ttm)
$1.37B
Revenue Growth
+32.98%
P/S Ratio
5.79
Revenue / Employee
$1,637,434
Employees
834
Market Cap
7.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.30B361.37M38.65%
Dec 31, 2022935.06M509.85M119.91%
Dec 31, 2021425.21M85.80M25.28%
Dec 31, 2020339.41M-7.93M-2.28%
Dec 31, 2019347.34M3.96M1.15%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Ensign Group 3.97B
Chemed 2.29B
Ionis Pharmaceuticals 776.62M
Repligen 607.45M
Intra-Cellular Therapies 513.93M
Ascendis Pharma 357.63M
Roivant Sciences 124.80M
Revolution Medicines 4.57M
Revenue Rankings